Roger W. Robinson


Roger W. Robinson was an American cardiologist who served as Chief of Cardiology and Chief of Medicine at Memorial Hospital, Worcester, MA. He was the director of the Lipid Research Laboratory and served as a professor at the University of Massachusetts Medical School. He is considered a pioneer in the field of lipid and atherosclerosis research.

Early life and career

Dr. Robinson was born in Buffalo, NY on July 22, 1909 to William W. and Anna Robinson. He graduated Northwestern University Medical School in 1935 and completed his post graduate training in medicine at Peter Bent Brigham Hospital in Boston, MA. He joined Memorial Hospital in Worcester, MA in 1939 and served there in various roles over the ensuing 50 years. He served as an Army physician during World War II, as Chief of Cardiology and subsequently as Chief of Medicine at UMass Memorial Medical Center. His own private fund raising campaign led to the creation of the Lipid Research Laboratory at Memorial, which he also directed until his retirement in 1989.
He was a professor at the University of Massachusetts Medical School, which he helped bring to Worcester.

Career in medicine

Since his early years at Memorial Hospital and despite the lack of a laboratory or paid staff, Dr. Robinson engaged in research. Over the years, research funding from private and government funds, led to the development of a large research team with access to advanced lipid research equipment. Dr. Robinson recognized the role of cholesterol and diet in atherosclerotic heart disease and demonstrated that heparin prevents arterial clots.
His research led to the identification of lipid-lowering effects of the female hormone estrogen and he performed the earliest studies of estrogen supplementation in men and post-menopausal women. Dr. Robinson also conducted research on strokes; his 20-year follow-up study of 1000 stroke patients is still the largest published research on the natural history of strokes.

Willard House and Clock Museum

Dr. Robinson, along with his wife Imogene, co-founded The Willard House and Clock Museum in Grafton, which he served as President and Chairman of the Trustees. The museum was created through Dr. Robinson’s generosity and successful fund raising efforts, as well as his wife’s vision and more than 20 years of love and dedication to the museum’s daily operation. Even while still working in medicine Dr. Robinson would greet guests and give tours at the Willard Museum.

Death and legacy

Dr. Roger W Robinson died at home on November 11, 2010.
The Roger W. Robinson Fund was created in his memory. The Fund has supported work in cardiovascular research, endocrinology, hematology and headache research and has helped purchase important laboratory equipment. An annual lecture series on Cardiovascular Disease continues today, in gratitude for his many contributions to the training of generations of medical students and house officers.
YearLecturerTopic
11989Jay N Cohn, MDNew Concepts of the Pathophysiology, Treatment and Prognosis of Heart Failure
21990Stephen E Epstein, MDAngina with Normal Coronary Arteries: A Generalized Disorder of Smooth Muscle
31991Eric J Topol, MDThrombolytic Therapy for Acute Myocardial Infarction
41992Valentin Fuster, MDProgression and Regression of Coronary Atherogenesis: Evolving Concepts
51993Robert A O'Rourke, MDManagement of the Post MI Patient: When is Coronary Arteriography Really Indicated?
61994Thomas W Smith, MDManagement of the Patient with Heart Failure: New Insights and Clinical Implications
71995B Greg Brown, MD PhDThe Effects of Lipid Lowering Therapy on Coronary Atherosclerosis and Clinical Events
81996Robert L Frye, MDA Perspective of Coronary Revascularization
91997Shahbudin H Rahimtoola,
MB FRCP MACP
Hibernating Myocardium
101998J Warren Harthorne, MDElectrotherapy: Past, Present, and Future
111999Roger M Mills, MDHeart Failure and Transplantation Perspectives at the End of the Decade
122000Anthony N DeMaria, MDThree Dimension Echocardiography: Promises and Challenges
132001Victor Dzau, MDGene and Cell-based Therapies for Cardiovascular Disease
142002James J Ferguson III, MDThe Evolving Standard of Care for Acute Coronary Syndromes
152003James E Muller, MDDiagnosis and Treatment of Vulnerable Plaque
162004Alfred F Parisi, MDFrom Infection to Inflammation: Fifty Years of Cardiology
172005Robert Vogel, MDThe Vascular Biology of Coronary Risk Factors
182006Marc A Pfeffer, MD PhDCardiovascular Events in Cancer Trials and Cancer Events in Cardiovascular Trials
192007Peter C Block, MDPercutaneous Repair and Replacement for Valvular Heart Disease
202008George Beller, MDDiagnostic and Prognostic Applications of Multimodality Imaging in Coronary
Artery Disease
212009William Gaasch, MDLeft Ventricular Diastolic Dysfunction and Heart Failure
222010Peter R Kowey, MDNew Therapies in Atrial Fibrillation
232011Joseph Alpert, MDChanging Demographics in the US and the World and Its Effects on Clinical Medicine
242012-13Robert A Phillips, MD PhDHypertension and Hypertrophy: Impacting and Predicting Renal and CV
Outcomes in Chronic Kidney Disease
252014-15Nikolaos Kakouros, MRCP PhDInterventional Options for the Elderly with Cardiovascular disease